Last updated: March 15, 2023
Sponsor: May Institute
Overall Status: Active - Recruiting
Phase
N/A
Condition
Williams Syndrome
Asperger's Disorder
Autism
Treatment
N/AClinical Study ID
NCT04533607
R324A200154
Ages 5-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Educational classification of autism spectrum disorder
- Attending a public elementary school (K-6th grade)
- Attending school in person at least one day per week
- No planned changes in school placement or core team members in upcoming school year
- Parents/guardians able to participate in study-related activities (e.g., informedconsent process and completion of study measures)
- Child's teacher consents to participate
Exclusion
Exclusion Criteria:
- Profound vision or hearing loss
- Motor disabilities such as cerebral palsy
- Genetic disorder known to be associated with ASD such as Fragile X, Down Syndrome,tuberous sclerosis
Study Design
Total Participants: 120
Study Start date:
November 04, 2020
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
University of South Florida
Tampa, Florida 33612
United StatesActive - Recruiting
Kaitlin M Gould
Randolph, Massachusetts 02368
United StatesActive - Recruiting
University of Rochester
Rochester, New York 14642
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.